Health Robotics enters distribution agreements with Newico and Apta Medica for 7 new European countries

Oct 11 2010

Health Robotics today announced that it recently signed exclusive distribution agreements for its CytoCare, i.v.STATION, and i.v.SOFT world-leading technologies in seven new European countries with regional industry leaders Newico and Apta Medica, rapidly continuing on its worldwide quest to pervasively provide safe and cost-effective Intravenous (IV) Admixture Compounding Automation to hospitals all over the world.

"The investment we recently made on Europe-hosted symposiums such as EAHP and ISOPP, and the recent success of our Robots at Catholic University of Louvain-St. Luc, Mainz University Hospital, and Val d'Hebron University Hospital have enabled Health Robotics to continue its torrid momentum by expanding into 10 new European countries this quarter", stated Gaspar DeViedma, Health Robotics' Executive Vice President.

"As a former Director at Ljubljana University Hospital, I was very impressed with Health Robotics' new manufacturing and quality control facilities and the performance of its Robots. Health Robotics' innovative software and related technologies will finally enable clinical pharmacists in the Former Yugoslav Republics to dedicate more time to patient care, clinical research, and to tackle new challenges in the quickly-changing pharmaceutical industry", stated Aljosa Rojec, Apta Medica's General Manager.

CytoCare is the first and only robotic system proven to work anywhere in the world for the safe and sterile preparation of Hazardous Intravenous Admixtures, including Chemotherapy, Monoclonal Antibody Therapy, and Gene Therapy. With 56 installations currently under contract in 17 countries, CytoCare has long proven its unmatched flexibility to adapt to diverse pharmacy workflows and proprietary IV consumables in 4 continents. While several companies attempted the development of Chemotherapy Robotics as far back as 22 years ago, Cytocare is still the only robot that has been able to break the entry-barrier into the Intravenous Chemotherapy Automation Sector.

"I look forward to work with Newico and Apta Medica in quickly deploying our unique and world-leading technologies in their respective regional markets. Newico's own experience with Oral Medication Robotics is an ideal complement to Health Robotics' I.V. technology and "know-how", and Apta Medica's extensive distribution and service network within the Former Yugoslav Republics ensures that Health Robotics can continue to focus on its core competences while selectively partnering with well-established, local, and best-of-class marketing and service organizations", concluded Mr. DeViedma.